Trials / Completed
CompletedNCT07254442
Investigation of the Impact of Medications Used in COVID-19 Treatment and COVID-19 Vaccine on Hearing
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 90 (actual)
- Sponsor
- Zonguldak Bulent Ecevit University · Academic / Other
- Sex
- All
- Age
- 18 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
Investigation of the Impact of Medications Used in COVID-19 Treatment and COVID-19 Vaccine on Hearing
Detailed description
This study aims to investigate the impact of medications containing the active ingredients hydroxychloroquine and favipiravir on the auditory system, as well as to examine the effect of COVID-19 on hearing and its potential relationship with medication use and COVID-19 vaccine dose.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Hearing tests | Participants' pure tone thresholds, high frequency thresholds, and otoacoustic emissions measurements were evaluated. |
Timeline
- Start date
- 2021-12-01
- Primary completion
- 2022-02-01
- Completion
- 2022-03-01
- First posted
- 2025-11-28
- Last updated
- 2025-11-28
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT07254442. Inclusion in this directory is not an endorsement.